Cash Balance: Ended the year with $754 million in cash. Operating Expenses: 35% reduction in pro forma operating expenses year over year. 2026 Cash Operating Expenses: Expected to be under $390 ...

Recursion Pharmaceuticals reported its fourth-quarter 2025 earnings, showcasing a significant beat on both earnings and revenue forecasts. The company reported an EPS of -$0.21, surpassing the ...

Najat Khan: Good morning, and thank you so much for joining us. I want to start by briefly framing where Recursion Pharmaceuticals, Inc. is today in its journey and evolution. Over the past decade, ...

REC-4881 shows positive Phase 2 proof‑of‑concept in FAP: 4 mg once daily produced ~43% median polyp burden reduction and a 75% response rate with mostly grade 1/2 adverse events, and Recursion plans ...

THE sister of a model feared murdered after disappearing three decades ago says a new inquest has left more questions than answers. Revelle Balmain, 22, was set to travel to Japan on November 5, 1994 ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Pennsylvania residents can enter limited-release lotteries this week for the chance to purchase from over 1,400 bottles of rare whiskeys. Entrants have until 5 p.m. Friday to enter one or more of the ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...